Phase I trial of GBR 500.

Trial Profile

Phase I trial of GBR 500.

Completed
Phase of Trial: Phase I

Latest Information Update: 16 May 2011

At a glance

  • Drugs Vatelizumab (Primary)
  • Indications Chronic obstructive pulmonary disease; Inflammatory bowel diseases; Multiple sclerosis
  • Focus Adverse reactions
  • Sponsors Glenmark Pharmaceuticals Ltd
  • Most Recent Events

    • 18 Sep 2008 New trial record.
    • 11 Sep 2008 IND submitted to the US FDA.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top